Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Postoperative Anticoagulant Therapy in AVF
NCT04164693Completed
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Jan 2019
- Primary completion
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of enoxaparin and warfarin in thrombosis (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Blood flow of arteriovenous fistula at 12 months, arteriovenous fistula dysfunction or occlusion at 12 months and 2 more. Started Jan 2019; status: completed.
02
Drugs
enoxaparinwarfarin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT04164693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04164693.